FR2347382A1 - 11A-AMINO, D4 OR D5 PREGNANES AND ANDROSTANES WITH DISUBSTITUTED AMINO GROUP - Google Patents

11A-AMINO, D4 OR D5 PREGNANES AND ANDROSTANES WITH DISUBSTITUTED AMINO GROUP

Info

Publication number
FR2347382A1
FR2347382A1 FR7710271A FR7710271A FR2347382A1 FR 2347382 A1 FR2347382 A1 FR 2347382A1 FR 7710271 A FR7710271 A FR 7710271A FR 7710271 A FR7710271 A FR 7710271A FR 2347382 A1 FR2347382 A1 FR 2347382A1
Authority
FR
France
Prior art keywords
amino
androstanes
pregnanes
disubstituted
amino group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7710271A
Other languages
French (fr)
Other versions
FR2347382B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2347382A1 publication Critical patent/FR2347382A1/en
Application granted granted Critical
Publication of FR2347382B1 publication Critical patent/FR2347382B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7710271A 1976-04-05 1977-04-05 11A-AMINO, D4 OR D5 PREGNANES AND ANDROSTANES WITH DISUBSTITUTED AMINO GROUP Granted FR2347382A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB13707/76A GB1581234A (en) 1976-04-05 1976-04-05 11a - amino - 3a - hydroxysteroids

Publications (2)

Publication Number Publication Date
FR2347382A1 true FR2347382A1 (en) 1977-11-04
FR2347382B1 FR2347382B1 (en) 1982-01-08

Family

ID=10027931

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7710271A Granted FR2347382A1 (en) 1976-04-05 1977-04-05 11A-AMINO, D4 OR D5 PREGNANES AND ANDROSTANES WITH DISUBSTITUTED AMINO GROUP
FR8110329A Withdrawn FR2485020A1 (en) 1976-04-05 1981-05-25 11A-AMINO, 4 OR 5 PREGNANES AND ANDROSTANES

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8110329A Withdrawn FR2485020A1 (en) 1976-04-05 1981-05-25 11A-AMINO, 4 OR 5 PREGNANES AND ANDROSTANES

Country Status (19)

Country Link
JP (1) JPS52142056A (en)
AU (1) AU517206B2 (en)
BE (1) BE853227A (en)
DE (1) DE2715078A1 (en)
DK (1) DK148677A (en)
ES (1) ES457507A1 (en)
FI (1) FI771046A (en)
FR (2) FR2347382A1 (en)
GB (1) GB1581234A (en)
IE (1) IE45276B1 (en)
IL (1) IL51816A (en)
IT (1) IT1073232B (en)
LU (1) LU77064A1 (en)
NL (1) NL7703667A (en)
NO (1) NO771197L (en)
NZ (1) NZ183775A (en)
PL (1) PL197186A1 (en)
SE (1) SE7703929L (en)
ZA (1) ZA772029B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044227A1 (en) * 1980-07-16 1982-01-20 Glaxo Group Limited 11-Alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
FR2487359A1 (en) * 1980-07-16 1982-01-29 Glaxo Group Ltd 11A-AMINO-ANDROSTANES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
EP0059637A1 (en) * 1981-03-02 1982-09-08 Glaxo Group Limited 11Alpha-amino-3 Beta-hydroxy-androstanes

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57203099A (en) * 1981-05-29 1982-12-13 Glaxo Group Ltd 11 alpha-amino-androstane compound
JPS57203100A (en) * 1981-05-29 1982-12-13 Glaxo Group Ltd 11 alpha-amino-androstanes
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
FR2910002B1 (en) * 2006-12-13 2009-01-30 Sanofi Aventis Sa NOVEL METHOD FOR THE DIASTEREOSELECTIVE OBTAINING OF A PRIMARY CHIRAL AMINE ON A STEROID
JP2010037243A (en) * 2008-08-04 2010-02-18 Mitsubishi Rayon Co Ltd Method for producing norbornene lactone monomer
EP2766380B1 (en) 2011-10-14 2019-04-24 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
CN112472814A (en) 2012-01-23 2021-03-12 萨奇治疗股份有限公司 Neuroactive steroid formulations and methods of treating central nervous system disorders
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
PL2986624T3 (en) 2013-04-17 2020-11-16 Sage Therapeutics, Inc. 19-nor neuroactive steroids for methods of treatment
US9512165B2 (en) 2013-04-17 2016-12-06 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
DK3021852T3 (en) * 2013-07-19 2021-03-15 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS AND USES
CA3235088A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SG10202009859YA (en) 2014-10-16 2020-11-27 Sage Therapeutics Inc Compositions and methods for treating cns disorders
EP3206493B1 (en) 2014-10-16 2020-05-06 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
US10774108B2 (en) 2014-11-27 2020-09-15 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3250210B1 (en) 2015-01-26 2020-12-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
ES2935476T3 (en) 2015-02-20 2023-03-07 Sage Therapeutics Inc Neuroactive steroids, compositions and uses thereof
CA3158448A1 (en) 2016-03-08 2017-09-14 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3481845T3 (en) 2016-07-11 2023-11-27 Sage Therapeutics Inc C17, C20 AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
JP7065825B2 (en) 2016-07-11 2022-05-12 セージ セラピューティクス， インコーポレイテッド C7, C12, and C16 replacement neurostimulatory steroids and how to use them
CA3086189A1 (en) * 2017-12-22 2019-06-27 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
CA3120872A1 (en) 2018-12-05 2020-06-11 Sage Therapeutics, Inc. Neuroactive steroids and their methods of use
US11643434B2 (en) 2019-05-31 2023-05-09 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof
EP3990468A1 (en) * 2019-06-27 2022-05-04 Sage Therapeutics, Inc. Compounds for treating cns disorders
JP2022538300A (en) * 2019-06-27 2022-09-01 セージ セラピューティクス， インコーポレイテッド Compositions and methods for treating CNS disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2982775A (en) * 1957-05-06 1961-05-02 Schering Corp 11-oximino-, amino- and acylaminosteroids

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044227A1 (en) * 1980-07-16 1982-01-20 Glaxo Group Limited 11-Alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
FR2487359A1 (en) * 1980-07-16 1982-01-29 Glaxo Group Ltd 11A-AMINO-ANDROSTANES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
EP0059637A1 (en) * 1981-03-02 1982-09-08 Glaxo Group Limited 11Alpha-amino-3 Beta-hydroxy-androstanes

Also Published As

Publication number Publication date
IE45276L (en) 1977-10-05
NZ183775A (en) 1979-12-11
NL7703667A (en) 1977-10-07
JPS52142056A (en) 1977-11-26
DK148677A (en) 1977-10-06
ZA772029B (en) 1978-11-29
FI771046A (en) 1977-10-06
FR2485020A1 (en) 1981-12-24
PL197186A1 (en) 1979-06-18
SE7703929L (en) 1978-10-27
GB1581234A (en) 1980-12-10
LU77064A1 (en) 1979-01-18
IT1073232B (en) 1985-04-13
BE853227A (en) 1977-10-04
ES457507A1 (en) 1978-03-16
DE2715078A1 (en) 1977-10-13
IE45276B1 (en) 1982-07-28
AU517206B2 (en) 1981-07-16
AU2394277A (en) 1978-10-12
IL51816A (en) 1981-09-13
NO771197L (en) 1977-10-06
FR2347382B1 (en) 1982-01-08
IL51816A0 (en) 1977-06-30

Similar Documents

Publication Publication Date Title
FR2347382A1 (en) 11A-AMINO, D4 OR D5 PREGNANES AND ANDROSTANES WITH DISUBSTITUTED AMINO GROUP
NL7711591A (en) DIAPER FASTENING.
NL7604501A (en) COMBINED FAST AND REGULATING VALVE.
NL172983C (en) PNEUMATIC AND ELASTIC SPRING AND ANTI-VIOLATING SUPPORT.
BE844445A (en) GROUP WITH COMBINED VALVES AND INDEPENDENT CONTROLS
SE7508927L (en) PEPTIDE CYCLOPROPYLAMIDES WITH LH-RH / FSH-RH ACTION.
NL7612097A (en) BUTTERFLY VALVE.
NL7601421A (en) BOLT-SHAPED FASTENER.
FR2319061A1 (en) GROUP WITH TWO COMBINED VALVES AND INDEPENDENT CONTROLS
DE2728648A1 (en) THROTTLE VALVE
AT369875B (en) FLAP VALVE
IT1085381B (en) PROTEOLYTIC ENZYME, ITS PREPARATION AND USE
NO139182C (en) RESTRICTED ROOF WITH ROOF CHAIRS MADE AS A TRANSACTION WITH LOWER BELT AND UPPER BELTS
TR19861A (en) SPINNING AND BUEKME ALLELIT
NO156435C (en) FASTENER.
ES229670Y (en) BUTTERFLY VALVE.
NL7713324A (en) 1-CYCLOALKYLCARBONYL-3- (3,5-DIHALOGEN-PHENYL) IMI-DAZOLIDINE-2,4-DIONES.
SE7505673L (en) LOAD-UP AND METHOD-APPARATUS.
SU512276A1 (en) Retainer
SU512430A1 (en) Thermoanemometer
NL7701049A (en) BUTTERFLY VALVE.
NL172889B (en) THROTTLE VALVE.
NL7601496A (en) SECURING AND SEALING.
NL7707831A (en) CURVED SENSITIVE ANALOGUE COUNTER TUBE.
NL7607625A (en) 1,3-DIHYDRO-3-PHENYL-1 '- (2-PROPYNYL) SPIRO (ISO-BENZOFURAN) AND.

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse